Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP)

NIH RePORTER · NIH · R01 · $732,810 · view on reporter.nih.gov ↗

Abstract

ABSTRACT The goal of this project is to establish routinely successful prolonged normothermic ex vivo heart perfusion (NEVHP) leading to organ banks. We have demonstrated routinely successful ex vivo heart perfusion for 24-72 hours using plasma exchange with a paracorporeal animal, then fresh plasma alone, then continuous hemofiltration in sheep and pigs. The experiments proposed in this application are planned to determine the factors responsible for prolonged NEVHP and demonstrate routine 3-day successful ex vivo perfusion. This would allow heart treatment, verifying heart function, near perfect matching, increase donors, and make heart transplantation elective. In addition, the NEVHP protocols and systems will be tested to resuscitate hearts after prolonged periods of cold ischemia and hearts from DCD. Critical step prior translated the animal models into clinical practice. Lessons from the research with hearts will apply to other organs.

Key facts

NIH application ID
10889078
Project number
5R01HL161139-03
Recipient
UNIVERSITY OF MICHIGAN AT ANN ARBOR
Principal Investigator
Alvaro Rojas-Pena
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$732,810
Award type
5
Project period
2022-09-01 → 2026-06-30